Get started
Author

Soe Moe

Observed names: Moe Soe, S. Moe
ORCID: 0000-0002-2527-592X
Observed ORCID: 0000-0002-2527-592X
OpenAlex ID: A5039788756
The Effectiveness and Safety of Bedaquiline, Pretomanid, and Linezolid (BPaL)–Based Regimens for Rifampicin-Resistant Tuberculosis in Non-Trial Settings—A Prospective Cohort Study in Belarus and Uzbekistan
2025 · Animesh Sinha, Roland Klebe, et al. · Clinical Infectious Diseases · 17
How much should we still worry about QTc prolongation in rifampicin-resistant tuberculosis? ECG findings from TB-PRACTECAL clinical trial
2024 · Ilaria Motta, Martina Cusinato, et al. · Antimicrobial Agents and Chemotherapy · 10
Primary bedaquiline resistance in Karakalpakstan, Uzbekistan
2023 · S. Moe, M. L. Rekart, et al. · The International Journal of Tuberculosis and Lung Disease · 9
Second-line drug-resistant TB and associated risk factors in Karakalpakstan, Uzbekistan
2024 · S. Moe, I. Azamat, et al. · IJTLD OPEN · 8
Characteristics, Treatment Strategies, and Long-term Health Outcomes of People With Bedaquiline-resistant Tuberculosis in Karakalpakstan, Uzbekistan—A Retrospective Cohort Study
2026 · Matthew J Saunders, Ekaterine Garsevanidze, et al. · Open Forum Infectious Diseases
Works count: 5
Citation count: 44
H-index: 4
I10-index: 2
Year
Topic
Type